Press Release / Business / Dengue Vaccine Market to Remain Lucrative During 2017 – 2027

Dengue Vaccine Market to Remain Lucrative During 2017 – 2027

XploreMR in its report titled “Dengue Vaccine Market: Global Industry Analysis and Opportunity Assessment, 2017–2027” offers detailed insights and in-depth research on the global dengue vaccine market over a 10 year forecast period 2017 – 2027. The report covers the important factors driving the growth of the global dengue vaccine market, untapped opportunities for manufacturers, trends and developments shaping the dynamics of the global dengue vaccine market and other insights across various key segments. The report identifies the drivers and restraints affecting the growth of the global dengue vaccine market. Changing trends are also analysed and incorporated in the report to provide exhaustive information about the market resulting in better decision making. Macroeconomic factors and forecast factors that directly and indirectly affect the growth of the global dengue vaccine market are also incorporated in the report. 
Click HERE To get SAMPLE PDF (Including Full TOC, Table & Figures) at https://www.xploremr.com/connectus/sample/5075
Report Description
The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global dengue vaccine market over the forecast period. Insights on key trends, drivers, restraints, value forecasts and opportunities for companies developing the dengue vaccine in the global dengue vaccine market are presented in the report. To understand and assess opportunities in this market, the report offers market forecast on the basis of end user and regions. The report provides analysis of the global dengue vaccine market in terms of market value (US$ Mn).
The report begins with the market introduction followed by the global market overview of the dengue vaccine. The market dynamics section includes XploreMR’ analysis of key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global dengue vaccine market. The report also analyses various issues of Dengvaxia, tiered pricing of dengue vaccine, sales channel strategy adoption, pipeline assessment, promotional activities adopted by Sanofi, and epidemiology of dengue.
Market Segmentation




By Product


By End User


By Region







CYD-TDV (Dengvaxia)




Hospitals
Government Institutes
Non-Governmental Organizations (NGOs)




North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding Japan
Middle East and Africa
Japan





In the final section of the report, a competitive landscape has been included to provide a dashboard view of key companies operating in the global dengue vaccine market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the global dengue vaccine market and the potential players. This section also includes market strategies and SWOT analysis of the main players operational in the global dengue vaccine market.
Click Here to Get Full Access of this Report @ https://www.xploremr.com/report/5075/dengue-vaccine-market/select-license
Research Methodology
We have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the global dengue vaccine market and to identify growth opportunities for companies operating in the global dengue vaccine market. Another important feature of our report is the analysis of key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity analysis is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered in the global dengue vaccine market. Furthermore, to understand key market segments in terms of their growth and performance in the global dengue vaccine market, XploreMR has developed a unique market attractiveness index to help providers identify existing market opportunities.  
The various sub segments of the global dengue vaccine market have also been analysed in terms of Basis Point Share (BPS) to understand individual segments’ relative contribution to market growth. This detailed level of information is important for identifying various key trends in the global dengue vaccine market.